Rasch model-based testing of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire–Chemotherapy-Induced Peripheral Neuropathy (QLQ-CIPN20) using Alliance for Clinical Trials in Oncology (Alliance) A151408 study data

Ellen M. Lavoie Smith, Noah Zanville, Grace Kanzawa-Lee, Clare Donohoe, Celia Bridges, Charles Loprinzi, Jennifer Le-Rademacher, James J. Yang

Open source

DOI: 10.1007/s00520-018-4553-y
Published: 2018-11-20
Container: Supportive Care in Cancer
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s00520-018-4553-y,
  title = {Rasch model-based testing of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire–Chemotherapy-Induced Peripheral Neuropathy (QLQ-CIPN20) using Alliance for Clinical Trials in Oncology (Alliance) A151408 study data},
  author = {Ellen M. Lavoie Smith and Noah Zanville and Grace Kanzawa-Lee and Clare Donohoe and Celia Bridges and Charles Loprinzi and Jennifer Le-Rademacher and James J. Yang},
  year = {2018},
  journal = {Supportive Care in Cancer},
  doi = {10.1007/s00520-018-4553-y},
  url = {https://doi.org/10.1007/s00520-018-4553-y}
}

RIS

TY  - JOUR
TI  - Rasch model-based testing of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire–Chemotherapy-Induced Peripheral Neuropathy (QLQ-CIPN20) using Alliance for Clinical Trials in Oncology (Alliance) A151408 study data
AU  - Ellen M. Lavoie Smith
AU  - Noah Zanville
AU  - Grace Kanzawa-Lee
AU  - Clare Donohoe
AU  - Celia Bridges
AU  - Charles Loprinzi
AU  - Jennifer Le-Rademacher
AU  - James J. Yang
PY  - 2018
JO  - Supportive Care in Cancer
DO  - 10.1007/s00520-018-4553-y
UR  - https://doi.org/10.1007/s00520-018-4553-y
ER  -

APA

Smith, E. M. L., Zanville, N., Kanzawa-Lee, G., Donohoe, C., Bridges, C., Loprinzi, C., Le-Rademacher, J., & Yang, J. J. (2018). Rasch model-based testing of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire–Chemotherapy-Induced Peripheral Neuropathy (QLQ-CIPN20) using Alliance for Clinical Trials in Oncology (Alliance) A151408 study data. Supportive Care in Cancer. https://doi.org/10.1007/s00520-018-4553-y

Source records

crossref · retrieved 2026-09-25T22:15:21.246Z